Literature DB >> 23199200

Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics.

Hyejung Mok1, Miqin Zhang.   

Abstract

INTRODUCTION: Superparamagnetic iron oxide nanoparticle (SPION)-based carrier systems have many advantages over other nanoparticle-based systems. They are biocompatible, biodegradable, facilely tunable and superparamagnetic and thus controllable by an external magnetic field. These attributes enable their broad biomedical applications. In particular, magnetically driven carriers are drawing considerable interest as an emerging therapeutic delivery system because of their superior delivery efficiency. AREAS COVERED: This article reviews the recent advances in use of SPION-based carrier systems to improve the delivery efficiency and target specificity of biotherapeutics. The authors examine various formulations of SPION-based delivery systems, including SPION micelles, clusters, hydrogels, liposomes and micro/nanospheres, as well as their specific applications in delivery of biotherapeutics. EXPERT OPINION: Recently, biotherapeutics including therapeutic cells, proteins and genes have been studied as alternative treatments to various diseases. Despite the advantages of high target specificity and low adverse effects, clinical translation of biotherapeutics has been hindered by the poor stability and low delivery efficiency compared with chemical drugs. Accordingly, biotherapeutic delivery systems that can overcome these limitations are actively pursued. SPION-based materials can be ideal candidates for developing such delivery systems because of their excellent biocompatibility and superparamagnetism that enables long-term accumulation/retention at target sites by utilization of a suitable magnet. In addition, synthesis technologies for production of finely tuned, homogeneous SPIONs have been well developed, which may promise their rapid clinical translation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199200      PMCID: PMC4167583          DOI: 10.1517/17425247.2013.747507

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  105 in total

1.  Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles.

Authors:  Anat Yanai; Urs O Häfeli; Andrew L Metcalfe; Peter Soema; Lois Addo; Cheryl Y Gregory-Evans; Kelvin Po; Xianghong Shan; Orson L Moritz; Kevin Gregory-Evans
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

Review 2.  Protein therapeutics: a summary and pharmacological classification.

Authors:  Benjamin Leader; Quentin J Baca; David E Golan
Journal:  Nat Rev Drug Discov       Date:  2008-01       Impact factor: 84.694

3.  Quantitative intracellular magnetic nanoparticle uptake measured by live cell magnetophoresis.

Authors:  Ying Jing; Niladri Mal; P Stephen Williams; Maritza Mayorga; Marc S Penn; Jeffrey J Chalmers; Maciej Zborowski
Journal:  FASEB J       Date:  2008-08-25       Impact factor: 5.191

Review 4.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  Improved transfection of HUVEC and MEF cells using DNA complexes with magnetic nanoparticles in an oscillating field.

Authors:  Jenson Lim; Jon Dobson
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

Review 6.  Analysis on the current status of targeted drug delivery to tumors.

Authors:  Il Keun Kwon; Sang Cheon Lee; Bumsoo Han; Kinam Park
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

7.  Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response.

Authors:  Young-Woock Noh; Yong-Suk Jang; Kook-Jin Ahn; Yong Taik Lim; Bong Hyun Chung
Journal:  Biomaterials       Date:  2011-05-26       Impact factor: 12.479

8.  Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction.

Authors:  Ke Cheng; Tao-Sheng Li; Konstantinos Malliaras; Darryl R Davis; Yiqiang Zhang; Eduardo Marbán
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

9.  Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles.

Authors:  J-J Yuan; S P Armes; Y Takabayashi; K Prassides; C A P Leite; F Galembeck; A L Lewis
Journal:  Langmuir       Date:  2006-12-19       Impact factor: 3.882

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  23 in total

Review 1.  Fundamentals and application of magnetic particles in cell isolation and enrichment: a review.

Authors:  Brian D Plouffe; Shashi K Murthy; Laura H Lewis
Journal:  Rep Prog Phys       Date:  2014-12-04

Review 2.  Current status of non-viral gene therapy for CNS disorders.

Authors:  Rahul Dev Jayant; Daniela Sosa; Ajeet Kaushik; Venkata Atluri; Arti Vashist; Asahi Tomitaka; Madhavan Nair
Journal:  Expert Opin Drug Deliv       Date:  2016-06-01       Impact factor: 6.648

Review 3.  Nanoparticles for imaging and treatment of metastatic breast cancer.

Authors:  Qingxin Mu; Hui Wang; Miqin Zhang
Journal:  Expert Opin Drug Deliv       Date:  2016-07-19       Impact factor: 6.648

Review 4.  Synthetic immunosurveillance systems: nanodevices to monitor physiological events.

Authors:  Yvon L Woappi; Rahul Jangiti; Om V Singh
Journal:  Biosens Bioelectron       Date:  2014-05-10       Impact factor: 10.618

Review 5.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

6.  MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.

Authors:  Sakiko Yoshida; Connie Duong; Michael Oestergaard; Michael Fazio; Cathy Chen; Rachael Peralta; Shuling Guo; Punit P Seth; Yueju Li; Laurel Beckett; Nitin Nitin; Noriko Satake
Journal:  Nanomedicine       Date:  2019-11-26       Impact factor: 5.307

Review 7.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies.

Authors:  Daniela Y Santiesteban; Kelsey Kubelick; Kabir S Dhada; Diego Dumani; Laura Suggs; Stanislav Emelianov
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 4.219

8.  Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery.

Authors:  Iva Blazkova; Hoai Viet Nguyen; Simona Dostalova; Pavel Kopel; Maja Stanisavljevic; Marketa Vaculovicova; Marie Stiborova; Tomas Eckschlager; Rene Kizek; Vojtech Adam
Journal:  Int J Mol Sci       Date:  2013-06-27       Impact factor: 5.923

9.  Bionanotechnology and the future of glioma.

Authors:  Peter A Chiarelli; Forrest M Kievit; Miqin Zhang; Richard G Ellenbogen
Journal:  Surg Neurol Int       Date:  2015-02-13

Review 10.  Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.

Authors:  Jafrin Jobayer Sonju; Achyut Dahal; Sitanshu S Singh; Seetharama D Jois
Journal:  J Control Release       Date:  2020-10-01       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.